Nurse Practitioner · Shreveport, LA
NPI
1770581274
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1541 Kings Hwy
Shreveport, LA, 71103
Phone (318) 626-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,190
52 services
Medicare patients, 2024
32
Average age 52
Drug cost, 2024
$5.8M
2,067 prescriptions
Company payments, 2025
$345
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon D Adley was code 99214 (office e&m - established), 34 times for 24 patients. In total Sharon D Adley billed 52 services in 2 codes, and Medicare paid $2,190.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 34 | 24 | $49.25 | $1,674 |
| 99213 Office E&M - Established | Facility | 17 | 14 | $30.33 | $516 |
By year: 2022 $3,491 for 97 services; 2023 $1,989 for 63 services; 2024 $2,190 for 52 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon D Adley prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 500 prescriptions and refills. In total Sharon D Adley wrote 2,067 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 500 | 500 | 71 | $2.0M |
| Juluca Dolutegravir/Rilpivirine | 307 | 307 | 36 | $1.1M |
| Tivicay Dolutegravir Sodium | 201 | 201 | 28 | $463K |
| Dovato Dolutegravir Sodium/Lamivudine | 182 | 186 | 22 | $546K |
| Descovy Emtricitabine/Tenofov Alafenam | 136 | 138 | 17 | $296K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 72 | 82 | 12 | $391K |
| Prezcobix Darunavir/Cobicistat | 59 | 59 | Under 11 | $144K |
| Cabenuva Cabotegravir/Rilpivirine | 44 | 78 | Under 11 | $290K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 41 | 47 | 12 | $117 |
| Valacyclovir Valacyclovir Hcl | 39 | 43 | Under 11 | $1,986 |
| Atovaquone Generic | 28 | 40 | Under 11 | $13K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 27 | 27 | Under 11 | $102K |
| Atorvastatin Calcium Generic | 18 | 30 | Under 11 | $69.41 |
| Eszopiclone Generic | 18 | 18 | Under 11 | $310 |
| Tenofovir Disoproxil Fumarate Generic | 16 | 30 | Under 11 | $186 |
Brand drugs: 1,625 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon D Adley $345 ($345 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $345.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 27 | $345 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.